BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,192,096 | -26.2% | 1,497,254 | -7.1% | 0.03% | -23.8% |
Q2 2023 | $101,826,639 | +29.9% | 1,611,181 | -7.5% | 0.04% | +23.5% |
Q1 2023 | $78,363,762 | +16.4% | 1,741,804 | +13.4% | 0.03% | +13.3% |
Q4 2022 | $67,298,951 | -27.5% | 1,536,155 | +9.0% | 0.03% | -33.3% |
Q3 2022 | $92,846,000 | +22.8% | 1,409,107 | -5.9% | 0.04% | +28.6% |
Q2 2022 | $75,634,000 | -21.6% | 1,497,405 | -0.9% | 0.04% | -5.4% |
Q1 2022 | $96,522,000 | -40.0% | 1,510,991 | +0.7% | 0.04% | -35.1% |
Q4 2021 | $160,745,000 | +12.1% | 1,500,745 | +7.6% | 0.06% | 0.0% |
Q3 2021 | $143,338,000 | +16.2% | 1,394,204 | -0.6% | 0.06% | +14.0% |
Q2 2021 | $123,341,000 | -9.3% | 1,402,239 | +0.2% | 0.05% | -16.7% |
Q1 2021 | $136,061,000 | -5.9% | 1,399,369 | +8.6% | 0.06% | -11.8% |
Q4 2020 | $144,539,000 | +17.9% | 1,288,805 | -2.6% | 0.07% | +3.0% |
Q3 2020 | $122,625,000 | +34.3% | 1,322,813 | +13.0% | 0.07% | +22.2% |
Q2 2020 | $91,324,000 | +43.9% | 1,170,824 | +7.9% | 0.05% | +17.4% |
Q1 2020 | $63,471,000 | -29.5% | 1,085,347 | -3.5% | 0.05% | -9.8% |
Q4 2019 | $90,082,000 | +15.4% | 1,124,473 | +5.8% | 0.05% | +4.1% |
Q3 2019 | $78,063,000 | -20.5% | 1,062,518 | +2.0% | 0.05% | -19.7% |
Q2 2019 | $98,232,000 | +23.7% | 1,041,370 | +5.0% | 0.06% | +17.3% |
Q1 2019 | $79,420,000 | +69.6% | 992,129 | +14.2% | 0.05% | +48.6% |
Q4 2018 | $46,841,000 | -41.6% | 868,870 | -15.4% | 0.04% | -32.7% |
Q3 2018 | $80,154,000 | +63.0% | 1,026,822 | +32.5% | 0.05% | +52.9% |
Q2 2018 | $49,184,000 | -33.5% | 774,794 | -3.9% | 0.03% | -35.8% |
Q1 2018 | $73,959,000 | +12.8% | 806,527 | -7.3% | 0.05% | +12.8% |
Q4 2017 | $65,589,000 | -12.3% | 869,767 | -19.0% | 0.05% | -16.1% |
Q3 2017 | $74,830,000 | +37.4% | 1,074,063 | -0.1% | 0.06% | +33.3% |
Q2 2017 | $54,451,000 | +40.0% | 1,074,629 | +10.5% | 0.04% | +35.5% |
Q1 2017 | $38,898,000 | +5093.3% | 972,699 | +3543.1% | 0.03% | +3000.0% |
Q4 2016 | $749,000 | -5.5% | 26,700 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $793,000 | +116.1% | 26,700 | +47.5% | 0.00% | – |
Q2 2016 | $367,000 | +24.0% | 18,100 | +10.4% | 0.00% | – |
Q1 2016 | $296,000 | -45.5% | 16,400 | -20.4% | 0.00% | – |
Q4 2015 | $543,000 | +65.0% | 20,600 | +33.8% | 0.00% | – |
Q3 2015 | $329,000 | -13.2% | 15,400 | +7.7% | 0.00% | – |
Q2 2015 | $379,000 | – | 14,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |